Inari Medical收到史赛克价值49亿美元的收购要约
周二，医疗科技公司Inari Medical盘前大涨超21%，昨日涨超30%。医疗设备制造商史赛克宣布，将以49亿美元的价格收购Inari Medical。
这一收购交易将有助于史赛克扩大其治疗静脉疾病的产品线。总部位于加利福尼亚州的Inari Medical是一家专门从事治疗肺栓塞、深静脉血栓和支架内血栓等疾病的设备和系统制造商。此举将显著增强史赛克公司在这一细分市场的实力。
此前一年，在静脉疾病治疗设备需求激增的大环境下，Inari Medical的股价逆市下跌约21%。此次收购无疑为公司和股东带来了重大利好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10